Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance

被引：0
|
作者：
Hong-Tao Xu
Jorge L Martinez-Cajas
Michel L Ntemgwa
Dimitrios Coutsinos
Fernando A Frankel
Bluma G Brenner
Mark A Wainberg
机构：
[1] Jewish General Hospital,McGill University AIDS Centre, Lady Davis Institute
[2] McGill University,Department of Medicine
[3] McGill University,Department of Microbiology and Immunology
来源：
Retrovirology | / 6卷
关键词：
Reverse Transcriptase Enzyme; Mutation K65R; dNTP Concentration; Reverse Transcriptase Code Region; K65R Reverse Transcriptase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Xu, Hong-Tao
    Martinez-Cajas, Jorge L.
    Ntemgwa, Michel L.
    Coutsinos, Dimitrios
    Frankel, Fernando A.
    Brenner, Bluma G.
    Wainberg, Mark A.
    RETROVIROLOGY, 2009, 6
  • [2] Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations
    Frankel, Fernando A.
    Invernizzi, Cedric F.
    Oliveira, Maureen
    Wainberg, Mark A.
    AIDS, 2007, 21 (06) : 665 - 675
  • [3] In vitro molecular characterization of the development of the K65R and M184V mutations in subtype C HIV-1
    Coutsinos, D.
    Invernizzi, C. F.
    Xu, H.
    Brenner, B. G.
    Wainberg, M. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S127 - S127
  • [4] Kinetics and chain termination studies performed with recombinant mutated M184V and K65R HIV reverse transcriptase
    Wainberg, MA
    Quan, Y
    Gu, Z
    Li, Z
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 5 - 5
  • [5] Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity
    White, KL
    Margot, NA
    Wrin, T
    Petropoulos, CJ
    Miller, MD
    Naeger, LK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3437 - 3446
  • [6] In vitro molecular characterization of the development of the K65R and M184V mutations in subtype CHIV-1
    Coutsinos, D.
    Invernizzi, C. F.
    Xu, H.
    Brenner, B. G.
    Wainberg, M. A.
    ANTIVIRAL THERAPY, 2007, 12 : S127 - S127
  • [7] Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    Deval, J
    White, KL
    Miller, MD
    Parkin, NT
    Courcambeck, J
    Halfon, P
    Selmi, B
    Boretto, J
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 509 - 516
  • [8] Dynamic of selection of the K65R and M184V/I mutations in patients enrolled in Tonus trial
    Delaunay, C
    Descamps, D
    Landman, R
    Peytavin, G
    Flandre, P
    Trylesinski, A
    Collin, G
    Benalycherif, A
    Monchecourt, F
    Brun-Vézinet, F
    ANTIVIRAL THERAPY, 2004, 9 (04) : U117 - U117
  • [9] The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations
    White, KL
    Chen, JM
    Feng, JY
    Morgot, NA
    Ly, JK
    Ray, AS
    MacArthur, HL
    McDermott, MJ
    Swaminathan, S
    Miller, MD
    ANTIVIRAL THERAPY, 2006, 11 (02) : 155 - 163
  • [10] Molecular modelling approach to explain the susceptibility of PMPA for drug-resistant HIV-1 reverse transcriptase:: K65R, Q151M and M184V
    Courcambeck, J
    Pèpe, G
    Halfon, P
    ANTIVIRAL THERAPY, 2002, 7 : S34 - S34
12345